[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should Know",
    "summary": "In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $512.52, indicating a +0.06% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=98fc121f7d0d3e8895f897200a6d6053149643d7984795f24169779a5ab01ad7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742421619,
      "headline": "Vertex Pharmaceuticals (VRTX) Rises But Trails Market: What Investors Should Know",
      "id": 133325406,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $512.52, indicating a +0.06% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=98fc121f7d0d3e8895f897200a6d6053149643d7984795f24169779a5ab01ad7"
    }
  },
  {
    "ts": null,
    "headline": "Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?",
    "summary": "We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best diabetes stocks to buy according to billionaires. The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The WHO […]",
    "url": "https://finnhub.io/api/news?id=b35d3c84f2e8c3d0419630e441c5aca4c762ff3a90aa0ff875ea5b870b28a091",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742393815,
      "headline": "Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?",
      "id": 133325407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best diabetes stocks to buy according to billionaires. The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The WHO […]",
      "url": "https://finnhub.io/api/news?id=b35d3c84f2e8c3d0419630e441c5aca4c762ff3a90aa0ff875ea5b870b28a091"
    }
  },
  {
    "ts": null,
    "headline": "Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next",
    "summary": "The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this.  Whatever happens, though, some stocks are still worth investing in and holding on to through market volatility.  Two excellent examples are DexCom (NASDAQ: DXCM) and Vertex Pharmaceuticals (NASDAQ: VRTX).",
    "url": "https://finnhub.io/api/news?id=989dc23fd50976f7c93b8d3b4525c25cd138e8d1acc996e1b49d20a19402920c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742392920,
      "headline": "Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next",
      "id": 133325408,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this.  Whatever happens, though, some stocks are still worth investing in and holding on to through market volatility.  Two excellent examples are DexCom (NASDAQ: DXCM) and Vertex Pharmaceuticals (NASDAQ: VRTX).",
      "url": "https://finnhub.io/api/news?id=989dc23fd50976f7c93b8d3b4525c25cd138e8d1acc996e1b49d20a19402920c"
    }
  },
  {
    "ts": null,
    "headline": "CRISPR Therapeutics AG (CRSP): A Bull Case Theory",
    "summary": "We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this article, we will summarize the bulls’ thesis on CRSP. CRISPR Therapeutics AG (CRSP)’s share was trading at $40.97 as of March 18th. CRSP’s trailing and forward P/E were 22.55 and 23.36 respectively according to Yahoo Finance. CRISPR Therapeutics […]",
    "url": "https://finnhub.io/api/news?id=a2f75f1f2e1f2cef3c70d20196a416aefdc9da1068f35e28efc5d88fc75dbc15",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742391707,
      "headline": "CRISPR Therapeutics AG (CRSP): A Bull Case Theory",
      "id": 133325409,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this article, we will summarize the bulls’ thesis on CRSP. CRISPR Therapeutics AG (CRSP)’s share was trading at $40.97 as of March 18th. CRSP’s trailing and forward P/E were 22.55 and 23.36 respectively according to Yahoo Finance. CRISPR Therapeutics […]",
      "url": "https://finnhub.io/api/news?id=a2f75f1f2e1f2cef3c70d20196a416aefdc9da1068f35e28efc5d88fc75dbc15"
    }
  },
  {
    "ts": null,
    "headline": "A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack",
    "summary": "Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season.",
    "url": "https://finnhub.io/api/news?id=58de3c880479f92f19e7e06b68c21f7daecfb386106851c9e25231da44197327",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742375111,
      "headline": "A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack",
      "id": 133325410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Let’s dig into the relative performance of Vertex Pharmaceuticals (NASDAQ:VRTX) and its peers as we unravel the now-completed Q4 therapeutics earnings season.",
      "url": "https://finnhub.io/api/news?id=58de3c880479f92f19e7e06b68c21f7daecfb386106851c9e25231da44197327"
    }
  }
]